A 19 F magnetic resonance imaging-based diagnostic test for bile acid diarrhea
JournalMagnetic Resonance Materials in Physics, Biology and Medicine
MetadataShow full item record
AbstractIn up to 50% of people diagnosed with a common ailment, diarrhea-predominant irritable bowel syndrome, diarrhea results from excess spillage of bile acids into the colon-data emerging over the past decade identified deficient release of a gut hormone, fibroblast growth factor 19 (FGF19), and a consequent lack of feedback suppression of bile acid synthesis as the most common cause. 75 Selenium homotaurocholic acid (SeHCAT) testing, considered the most sensitive and specific means of identifying individuals with bile acid diarrhea, is unavailable in many countries, including the United States. Other than SeHCAT, tests to diagnose bile acid diarrhea are cumbersome, non-specific, or insufficiently validated; clinicians commonly rely on a therapeutic trial of bile acid binders. Here, we review bile acid synthesis and transport, the pathogenesis of bile acid diarrhea, the reasons clinicians frequently overlook this disorder, including the limitations of currently available tests, and our efforts to develop a novel 19 F magnetic resonance imaging (MRI)-based diagnostic approach. We created 19 F-labeled bile acid analogues whose in vitro and in vivo transport mimics that of naturally occurring bile acids. Using dual 1 H/ 19 F MRI of the gallbladders of live mice fed 19 F-labeled bile acid analogues, we were able to differentiate wild-type mice from strains deficient in intestinal expression of a key bile acid transporter, the apical sodium-dependent bile acid transporter (ASBT), or FGF15, the mouse homologue of FGF19. In addition to reviewing our development of 19 F-labeled bile acid analogue-MRI to diagnose bile acid diarrhea, we discuss challenges to its clinical implementation. A major limitation is the paucity of clinical MRI facilities equipped with the appropriate coil and software needed to detect 19 F signals. © 2018, The Author(s).
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85055968188&doi=10.1007%2fs10334-018-0713-9&partnerID=40&md5=127a47219d8017777f9da9d245811a58; http://hdl.handle.net/10713/8599
- Attenuated Accumulation of Novel Fluorine (<sup>19</sup>F)-Labeled Bile Acid Analogues in Gallbladders of Fibroblast Growth Factor-15 (FGF15)-Deficient Mice.
- Authors: Metry M, Felton J, Cheng K, Xu S, Ai Y, Xue F, Raufman JP, Polli JE
- Issue date: 2018 Nov 5
- Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging.
- Authors: Vivian D, Cheng K, Khurana S, Xu S, Dawson PA, Raufman JP, Polli JE
- Issue date: 2014 Nov
- Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport.
- Authors: Felton J, Cheng K, Said A, Shang AC, Xu S, Vivian D, Metry M, Polli JE, Raufman JP
- Issue date: 2016 Nov 27
- Inhibition of ileal apical but not basolateral bile acid transport reduces atherosclerosis in apoE⁻/⁻ mice.
- Authors: Lan T, Haywood J, Dawson PA
- Issue date: 2013 Aug
- Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice.
- Authors: Cheng K, Metry M, Felton J, Shang AC, Drachenberg CB, Xu S, Zhan M, Schumacher J, Guo GL, Polli JE, Raufman JP
- Issue date: 2018 May 22